The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 350:327-330 January 22, 2004 Number 4
NextNext

Financial Conflicts of Interest and the NIH
Robert Steinbrook, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
The National Institutes of Health (NIH) is widely regarded as the world's premier biomedical research institution. The doubling of the NIH budget over the past decade reflects the trust that the American people place in this federal government agency and its employees, as well as the importance of its work. Recently, however, this confidence has been called into question by a report in the Los Angeles Times about consulting payments from pharmaceutical companies to high-ranking NIH officials.1

According to Dr. Elias A. Zerhouni, the director of the NIH, to date there is "no evidence that patients were harmed or that . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.